This article is more than 5 years old. Information may no longer be current.
FDA grants clearance for Ascensia glucose monitoring system app
Click Here to Manage Email Alerts
Ascensia Diabetes Care recently received FDA clearance for the Contour Next One blood glucose monitoring system, featuring a blood glucose smart meter that links to a mobile device through Bluetooth connectivity, according to a company release.
“This is an innovative new option for people living with diabetes,” Robert Schumm, head of Ascensia Diabetes Care U.S., said in the release. “The system combines the remarkable accuracy of the Contour Diabetes app and is designed to provide insights that may help people manage their diabetes in a better way.”
The Contour Diabetes app connects to the meter where patient blood glucose measurement information is collected, stored and analyzed.
“We believe the future of health care lies in connecting points of care,” Schumm said. “The first step in that journey for diabetes is to provide a connected system which can add value for people living with diabetes. Today, fewer than 2% of people living with diabetes use a connected meter. Contour Next One is designed to be simple-to-use, and can meet the needs of a broad group of users. The FDA clearance paves the way to providing this option for all those who may benefit from it.”
The system is expected to be available in the United States in early 2017, and the app will be available from the Apple App Story and Google Play.